Risch, Zug, Switzerland
Main responsibility: Disease Area Lead for Cardiometabolics & Diabetes As Healthcare Solution Lead, I drive the development and execution of strategic business plans across key market segments and disease areas, translating insights into growth opportunities and long-term value creation. Partnering closely with sales and cross-functional leadership, we identify high-potential customers, unlock volume opportunities, and establish sustainable partnerships that strengthen market position. I leverage in-depth market intelligence to uncover trends, competitive dynamics, and growth drivers, turning complex data into clear strategic direction and compelling executive presentations. My role includes evaluating strategic options through data-driven analyses, including make-versus-buy decisions, partnership models, and potential acquisitions. Assessment of joint ventures, collaborative agreements, and licensing opportunities, ensuring initiatives align with overarching business objectives and deliver measurable impact across the portfolio.
In this role, I led a cross-functional team to define and implement a comprehensive three-year strategy for the Cardiometabolics area. Together, we assessed market and business potentials, identified unmet medical needs, and developed actionable insights to guide strategic decision-making. A key part of the role involved evaluating opportunities for partnerships, both B2B and B2C, to expand our reach and impact across the patient journey. By integrating clinical, commercial, and market intelligence, we created a strategy that aligned medical innovation with business growth objectives and positioned the organization for sustainable success in the Cardiometabolics portfolio.
As Medical Manager for Cardiometabolics, I lead the strategic planning and operational execution of all medical activities within the Cardiometabolics portfolio in Switzerland. I focus on integrating key disease areas into a cohesive medical strategy that addresses patient needs across the continuum of care. I lead scientific engagement with internal teams and external key opinion leaders, translating clinical evidence into actionable insights that guide business and medical decisions. By aligning medical strategy with organizational objectives, I support portfolio growth, identify unmet medical needs, and enable evidence-based solutions that improve patient outcomes. Key achievements and responsibilities: - Developed and implemented integrated medical strategies for Cardiometabolics across Switzerland - Built and nurtured expert networks to support medical insights and strategic initiatives - Provided scientific leadership and guidance to cross-functional teams, ensuring medical excellence in all activities - Oversaw medical communications, educational programs, and initiatives grounded in robust clinical evidence
Coordination of experiments and coaching of scholar in the life science field.
Researching the impact of high altitude as well as hypoxia exposure on metastasis formation and spreading Humans living at high altitude are exposed to challenging environmental conditions – especially hypobaric hypoxia. Despite the chronical stress of hypoxia, humans living at high altitude show a reduced cancer mortality for various cancer types. Most of the physiological adaptations at high altitude occur in response to hypoxia, suggesting that hypoxia could be the driving force for the reduced cancer mortality. Because cancer malignancy and metastasis formation are the major reasons for cancer-related mortality, I investigated whether high altitude (Jungfraujoch Research Station at 3.500 m asl) and the related hypoxia decrease primary tumor growth and reduces metastasis formation.
Plasmodium Sporozoit Vaccine Clinical Trail in Tanzania